Asensus Surgical, Inc. (ASXC)

NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.800
-0.021 (-2.55%)
At close: Jan 31, 2023, 4:00 PM
0.817
+0.017 (2.17%)
Pre-market: Feb 1, 2023, 7:49 AM EST
-2.55%
Market Cap 189.47M
Revenue (ttm) 7.10M
Net Income (ttm) -73.55M
Shares Out 236.84M
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,061,414
Open 0.820
Previous Close 0.821
Day's Range 0.790 - 0.840
52-Week Range 0.280 - 0.930
Beta 1.38
Analysts Buy
Price Target 2.30 (+187.5%)
Earnings Date Feb 27, 2023

About ASXC

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Employees 153
Stock Exchange NYSEAMERICAN
Ticker Symbol ASXC
Full Company Profile

Financial Performance

In 2021, ASXC's revenue was $8.23 million, an increase of 159.28% compared to the previous year's $3.18 million. Losses were -$62.46 million, 4.06% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for ASXC stock is "Buy." The 12-month stock price forecast is $2.3, which is an increase of 187.50% from the latest price.

Price Target
$2.3
(187.50% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Asensus Surgical to Host Investor Day on February 21, 2023

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...

2 days ago - GlobeNewsWire

Asensus Surgical Receives CE Mark for Expanded Machine Vision Capabilities

Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers Expanded Intelligent Surgica...

1 week ago - GlobeNewsWire

Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update

RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...

3 weeks ago - GlobeNewsWire

Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...

3 weeks ago - GlobeNewsWire

Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System

First hospital to install a second Senhance Surgical System First hospital to install a second Senhance Surgical System

1 month ago - GlobeNewsWire

Asensus Announces Senhance Program Initiation at Kashiwa Kosei General Hospital of Japan

Continued expansion of the Senhance Program in the region Continued expansion of the Senhance Program in the region

1 month ago - GlobeNewsWire

Asensus Announces Senhance System Placement at GPR Klinikum Rüsselsheim of Germany

10th hospital in Germany to initiate a Senhance System 10th hospital in Germany to initiate a Senhance System

1 month ago - GlobeNewsWire

Asensus Announces Additional Senhance Surgical System Sale

Oncology focused hospital to initiate Senhance System program Oncology focused hospital to initiate Senhance System program

1 month ago - GlobeNewsWire

Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Office...

2 months ago - GlobeNewsWire

Asensus Surgical (ASXC) Reports Q3 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 25.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2022

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...

2 months ago - GlobeNewsWire

Asensus Surgical Announces Ludwig Maximilians University in Germany to Initiate Senhance Pediatric Surgery Program

RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...

3 months ago - GlobeNewsWire

Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 10, 2022

RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient...

3 months ago - GlobeNewsWire

Asensus Surgical, Inc. To Present at The LD Micro Main Event XV

Presentation on Tuesday, October 25 at 8:30 am PTResearch Triangle Park, North Carolina--(Newsfile Corp. - October 18, 2022) - Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical...

3 months ago - Newsfile Corp

Asensus Surgical Announces St. Bernhard Hospital in Germany to Initiate Senhance Surgery Program

System to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery System to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery

4 months ago - GlobeNewsWire

Asensus Surgical Announces Saiseikai Shiga Hospital in Japan to Initiate Senhance Surgery Program

RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pat...

5 months ago - GlobeNewsWire

3 Medical Instruments Stocks to Buy Despite Industry Headwinds

The Zacks Medical - Instruments industry is growing on R&D investments. SWAV, SMLR and ASXC are set to gain the most.

Other symbols: SMLRSWAV
5 months ago - Zacks Investment Research

Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference

RESEARCH TRIANGLE PARK, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Ra...

5 months ago - GlobeNewsWire

Asensus Surgical (ASXC) Reports Q2 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 12.50% and 20.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Asensus Surgical Announces Sale of Senhance Robotic System

Senhance System to be placed at hospital in the Commonwealth of Independent States Senhance System to be placed at hospital in the Commonwealth of Independent States

6 months ago - GlobeNewsWire

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 8, 2022

RESEARCH TRIANGLE PARK, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient...

6 months ago - GlobeNewsWire

Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

This becomes the 6th Senhance Hospital in Germany This becomes the 6th Senhance Hospital in Germany

7 months ago - GlobeNewsWire

Asensus Surgical to Showcase the Senhance Surgical System and Performance-Guided Surgery in Upcoming Society of Robotic and Digital Surgery Conference

RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the pati...

7 months ago - GlobeNewsWire

Asensus Surgical (ASXC) Reports Q1 Loss, Lags Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 12.50% and 18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2022

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ...

9 months ago - Business Wire